Signaling changes in the stem cell factor-AKT-S6 pathway in diagnostic AML samples are associated with disease relapse.
Blood Cancer J
; 1(2): e3, 2011 Feb.
Article
in En
| MEDLINE
| ID: mdl-22829109
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Blood Cancer J
Year:
2011
Document type:
Article